关注
Vishal Devarkonda
Vishal Devarkonda
Louisiana State University
在 lsuhs.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Obesity increases risk‐adjusted morbidity, mortality, and cost following cardiac surgery
RK Ghanta, DJ LaPar, Q Zhang, V Devarkonda, JM Isbell, LT Yarboro, ...
Journal of the American Heart Association 6 (3), e003831, 2017
1402017
Simultaneous targeting of 5-LOX-COX and EGFR blocks progression of pancreatic ductal adenocarcinoma
CV Rao, NB Janakiram, V Madka, V Devarkonda, M Brewer, L Biddick, ...
Oncotarget 6 (32), 33290, 2015
432015
Squamous cell carcinoma-A rare pancreatic exocrine malignancy
A Wahab, JJ Gonzalez, V Devarkonda, T Saint–Phard, T Singh, ...
Cancer Biology & Therapy 20 (5), 593-596, 2019
92019
Transcatheter interventions for severe tricuspid regurgitation: a literature review
PK Ponna, S Patin, NSS Turaga, DM Zoltowska, V Devarkonda, RK Botta, ...
Journal of Geriatric Cardiology: JGC 19 (7), 539, 2022
32022
Primary Immune Thrombocytopenic Purpura (ITP) and ITP Associated with Systemic Lupus Erythematosus: A Review of Clinical Characteristics and Treatment Modalities
KP Bashyal, S Shah, C Ghimire, S Balmuri, P Chaudhary, S Karki, ...
International Journal of Rheumatology 2024 (1), 6650921, 2024
12024
Complete Remission of Advanced Hepatocellular Carcinoma in a Patient With Ulcerative Colitis Treated With Atezolizumab and Bevacizumab: A Case Report
S Pentapati, S Caucci, S Balmuri, V Devarkonda
Cureus 15 (5), 2023
12023
Tachyarrhythmias burden in hospitalized patients with cancer: A nationwide propensity matched analysis.
M Kumar, S Ali, F Farooq, LY Byreddi, M Sultan, MS Afzal, B Nasir, ...
Journal of Clinical Oncology 42 (16_suppl), e24032-e24032, 2024
2024
Atrial flutter in a patient population with cancer: Comparison of incidence, mortality, and readmission rates.
MS Afzal, F Farooq, M Kumar, M Sultan, B Nasir, V Devarkonda, ...
Journal of Clinical Oncology 42 (16_suppl), e23079-e23079, 2024
2024
Incidence and outcomes of thromboembolic events in renal cancer related hospitalization in the United States: A propensity matched national study.
M Sultan, M Kumar, F Farooq, MS Afzal, B Nasir, LY Byreddi, S Atluri, ...
Journal of Clinical Oncology 42 (16_suppl), e16544-e16544, 2024
2024
Rural-urban disparities in colorectal cancer-related mortality changes in the United States.
LY Byreddi, S Atluri, SJ Gaddam, A Pothuraju, SLP Javvadi, ...
Journal of Clinical Oncology 42 (16_suppl), e13714-e13714, 2024
2024
Types of thromboembolic events and their outcomes among patients with active colorectal cancer: A nationwide propensity matched analysis.
F Farooq, M Kumar, MS Afzal, M Sultan, B Nasir, LY Byreddi, ...
Journal of Clinical Oncology 42 (16_suppl), e15530-e15530, 2024
2024
Thromboembolic incidents in prostate cancer patients: A nationwide propensity-matched study.
V Devarkonda, S Ali, M Kumar, F Farooq, LY Byreddi, M Sultan, MS Afzal, ...
Journal of Clinical Oncology 42 (16_suppl), e23082-e23082, 2024
2024
Incidence and outcomes of atrial fibrillation in different cancer subtypes: A propensity-matched analysis of Nationwide Readmissions Database.
F Farooq, M Kumar, M Sultan, MS Afzal, B Nasir, LY Byreddi, ...
Journal of Clinical Oncology 42 (16_suppl), e23324-e23324, 2024
2024
Comparing ventricular tachycardia across the nation: Stratification by different malignancies.
S Ali, M Kumar, F Farooq, V Devarkonda, LY Byreddi, M Sultan, S Atluri, ...
Journal of Clinical Oncology 42 (16_suppl), e23151-e23151, 2024
2024
Fibrous Dysplasia Masquerading as Sternal Malignancy: A Rare and Challenging Presentation
V Devarkonda, S Gaddam, M Morisetti, K Arora, K Beedupalli
Cureus 15 (12), 2023
2023
Adalimumab-associated Philadelphia chromosome positive acute lymphoblastic leukaemia in a patient with Crohn’s disease
V Devarkonda, S Balmuri, MACC Akabane, H Akabane
BMJ Case Reports CP 16 (10), e255604, 2023
2023
Transforming Acute Myeloid Leukemia Treatment Through Next-Generation Sequencing: A Single-Center Experience
V Devarkonda, H Akabane
Cureus 15 (9), 2023
2023
Acute Graft Versus Host Disease After Kidney-Pancreas Transplant
J Lopez, V Devarkonda, M Thuzar, R Silva, H Akabane
Cureus 15 (6), 2023
2023
Comparison of time of onset of leukemia with patients receiving adalimumab vs other TNF α inhibitors.
V Devarkonda, S Balmuri, SJ Gaddam, D Keerty, H Akabane
Journal of Clinical Oncology 41 (16_suppl), e19034-e19034, 2023
2023
Real-world experience with atezolizumab plus bevacizumab in the management of non-resectable hepatocellular carcinoma refractory to first-line systemic therapy: Review of …
V Devarkonda, LY Byreddi, S Balmuri, T Gudi, SJ Gaddam, D Keerty
Journal of Clinical Oncology 41 (16_suppl), e16189-e16189, 2023
2023
系统目前无法执行此操作,请稍后再试。
文章 1–20